Table 2. Epitope localization by mAb competitive binding assays.
mAb a | SylH3 | 24B11 | MH3 | 8A1 | 8B3 | LF1 | LC5 |
SylH3 | 97 | <10 | <10 | <10 | 85 | <10 | <10 |
24B11 | <10 | 96 | 91 | 55 | 92 | 95 | <10 |
MH3 | <10 | 37 | 89 | <10 | 43 | 34 | <10 |
8A1 | <10 | 35 | <10 | 81 | 45 | 57 | <10 |
8B3 | 87 | 79 | 86 | 21 | 92 | 93 | <10 |
LF1 | <10 | 50 | 56 | 26 | 62 | 95 | <10 |
LC5 | <10 | <10 | <10 | <10 | <10 | <10 | 79 |
a, competitive sandwich ELISAs were conducted as described in the Materials and Methods.
The capture mAbs (1 μg/ml) listed in the top row were coated on the 96 well microtiter plates, while the competitor mAbs (10 μg/ml) listed in the far left column were mixed with biotin-tagged ricin (equivalent to the EC90 for each coated mAb) in solution then applied to the microtiter plates. The numbers are the % inhibition of ricin capture, as defined in the Materials and Methods.